HYPERPHOSPHATEMIA

Clinical trials for HYPERPHOSPHATEMIA explained in plain language.

Never miss a new study

Get alerted when new HYPERPHOSPHATEMIA trials appear

Sign up with your email to follow new studies for HYPERPHOSPHATEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Completed 7

New drug trial aims to tame dangerous mineral in dialysis patients

Disease control Recruiting now

This study is testing whether a new drug called AP301 can safely lower high phosphate levels in the blood of people on long-term dialysis. Researchers will compare AP301 to a low-dose version in about 264 patients over 32 weeks to see which works better at controlling phosphate a…

Matched conditions: HYPERPHOSPHATEMIA

Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

HYPERPHOSPHATEMIA

Get alerted when new HYPERPHOSPHATEMIA trials appear

New drug trial aims to tame dangerous mineral in dialysis patients